New registry aims to unlock secrets of rare anemia
NCT ID NCT00106015
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is building a large database of people with Diamond Blackfan anemia, a rare inherited bone marrow condition that causes anemia. Researchers will collect medical information from up to 900 participants to better understand how the disease develops and progresses. The goal is to improve knowledge and eventually find better ways to diagnose and treat this condition.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this registry could help researchers better understand Diamond Blackfan anemia and guide future treatments.
- What could go wrong
- This is an observational registry, not a treatment trial. It will not directly test any therapy or provide immediate benefits to participants.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 900 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Sep 2004
- Expected to finish
-
Apr 2030
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
All subjects diagnosed with Diamond Blackfan anemia
- Ages
-
Children (under 18), adults (18 to 64) and older adults (65 and over)
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients must meet the diagnostic criteria for DBA which include the following: 1. Normochromic, usually macrocytic and occasionally normocytic anemia developing early in childhood 2. Reticulocytopenia 3. Normocellular bone marrow with a selective deficiency of red cell precursors 4. Normal or slightly decreased leukocyte count 5. Normal or often increased platelet count 6. Or, a confirmed mutation in one of the identified DBA genes Exclusion Criteria: * Any subject identified as having another bone marrow failure syndrome (eg. Fanconi anemia, dyskeratosis congenita, Shwachman Diamond syndrome, etc.) will be excluded.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Anemia are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Cohen Children's Medical Center of NY
RECRUITINGNew Hyde Park, New York, 11040, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can IV iron boost blood levels and daily energy for mothers before and after delivery?
- Iron boost before heart surgery may cut need for donor blood
- Can scheduled malaria drugs shield infants from severe illness?
- Can a simple preventive drug cut malaria and anemia in infants?
- Can catching anemia months before joint surgery speed recovery?
- Can a simple blood test predict surgery risks?